Feasibility of obtaining in situ nanocapsules through modified self-microemulsifying drug delivery systems. A new manufacturing approach for oral route administration

References

• Quintanar D, Allémann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 1998;24:1113–28.
   PubMed Web of Science ®Google Scholar
• Kreuter J. Nanoparticles. Colloidal drug delivery systems, drugs and the pharmaceutical sciences. Chapter 5, Vol. 66. New York: Marcel Dekker; 1994.
   Google Scholar
• Kumaresh S, Tejraj M, Anandrao K, Walter R. Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release 2001;70:1–20.
   PubMed Web of Science ®Google Scholar
• Fattal E. Nanoparticles as drug delivery systems. In: Wise DL, ed. Handbook of pharmaceutical controlled release technology. New York: CRC Press; 2000:1864–67.
   Google Scholar
• Schroeder U, Sommerfeld P, Ulrich S, Sabel BA. Nanoparticle technology for delivery of drugs across the blood-brain barrier. J Pharm Sci 1998;87:1305–7.
   PubMed Web of Science ®Google Scholar
• Raghuvanshi RS, Katare YK, Lalwani K, et al. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants. Int J Pharm 2002;245:109–21.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Petrov VE, Kharkevich DA, Alyautdin RN. Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after is delivery across the blood-brain barrier using surfactant-coated nanoparticles. J Control Release 1997;49:81.
   Web of Science ®Google Scholar
• Faraji HA, Wipf P. Nanoparticles in cellular drug delivery. Bioorg Med Chem 2009;17:2950–62.
   PubMed Web of Science ®Google Scholar
• Couvreur P, Barrat G, Fattal E, et al. Nanocapsule technology: a review. Crit Rev Ther Drug Carrier Syst 2002;19:99–134.
   PubMed Web of Science ®Google Scholar
• Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93–102.
   PubMed Web of Science ®Google Scholar
• Anton N, Benoit JP, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release 2008;128:185–99.
   PubMed Web of Science ®Google Scholar
• Mora Huertas CE, Fessi H, Elaissari A. Polymer-based nanocapsules for drug delivery. Int J Pharm 2010;385:113–42.
   PubMed Web of Science ®Google Scholar
• Duclairoir C, Nakache E, Marchais H, Orecchioni AM. Formation of gliadin nanoparticles: influence of the solubility parameter of the protein solvent. Colloid Polym Sci 1988;276:321–7.
   Web of Science ®Google Scholar
• Vauthier C, Bouchemal K. Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res 2008;26:1025–58.
   PubMed Web of Science ®Google Scholar
• Lawrence MJ, Rees DG. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2000;45:89–121.
   PubMed Web of Science ®Google Scholar
• Kohli K, Chopra S, Dhar D, et al. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today 2010;15:958–65.
   PubMed Web of Science ®Google Scholar
• Pouton CW. Formulation of self-smulsifying drug delivery systems. Adv Drug Deliv Rev 1997;25:47–58.
   Web of Science ®Google Scholar
• Sagitani H, Friberg S. Microemulsion systems with a non ionic surfactant. J Disper Sci Technol 1980;1:151–64.
   Web of Science ®Google Scholar
• Osborne DW, Middleton CA, Rogers RL. Alcohol-free microemulsions. J Disper Sci Technol 1988;9:415–23.
   Web of Science ®Google Scholar
• Attwood D, Mallon C, Taylor CJ. Phase studies of oil-in water phospholipid microemulsions. Int J Pharm 1992;84:R5–8.
   Web of Science ®Google Scholar
• Tenjarla S. Microemulsions: an overview and pharmaceutical applications. Crit Rev Ther Drug Carrier Syst 1999;16:461–521.
   PubMed Web of Science ®Google Scholar
• Elnaggar YSR, El-Massik MA, Abdallah OY. “Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization”. Int J Pharm 2009;380:133–41.
   PubMed Web of Science ®Google Scholar
• Mendoza-Muñoz N, Noriega-Peláez EK, Nava-Arzaluz MG, et al. Preparation and in vitro evaluation of poly (D,L-lactide-co-glycolide) air-filled nanocapsules as a contrast agent for ultrasound imaging. Ultrasonics 2011;51:839–45.
   PubMed Web of Science ®Google Scholar
• Rao RVS, Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int J Pharm 2008;362:2–9.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang P, Feng N, et al. Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int J Pharm 2009;365:136–42.
   PubMed Web of Science ®Google Scholar
• Ruschak KJ, Miller CA. Spontaneus emulsification in ternary systems with mass transfer. Ind Ing Chem Fundam. 1972;11:534–40.
   Web of Science ®Google Scholar
• Fessi HP, Devissaguet JP, Puisieux F, et al. Nanocapsule formation by interfacial polymer deposition following solvent deplacement. Int J Pharm 1989;55:25–8.
   Web of Science ®Google Scholar
• Calvo P, Vila-Jato JL, Alonso MJ. Comparative in vitro evaluation of several coloidal systems, nanoparticles, nanocapsules and nanoemulsions as ocular drug carriers. J Pharm Sci 1996;85:530–6.
   PubMed Web of Science ®Google Scholar
• Niwa T, Takeuchi H, Hino T, et al. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug behavior. J Control Rel 1993;25:89–98.
   Web of Science ®Google Scholar
• Fresta M, Puglisi G, Giammona G, et al. Pefloxacine mesilate- and ofloxacin-loaded polyethylcyanoacrylate nanoparticles: characterization of the colloidal drug carrier formulation. J Pharm Sci 1995;84:895–901.
   PubMed Web of Science ®Google Scholar
• Radwan MA. In vitro evaluation of polyisobutylcyanoacrylate nanoparticles as a controlled drug carrier for theophylline. Drug Dev Ind Pharm 1995;21:2371–5.
   Web of Science ®Google Scholar